Related Experiment Video
Updated: Nov 10, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
The PPAR-γ/SFRP5/Wnt/β-catenin signal axis regulates the dexamethasone-induced osteoporosis
1Shenzhen Institute of ENT & Longgang ENT Hospital, Shenzhen 518172, China.
Background:
The inhibition of glucocorticoid (GC) on osteoblastic differentiation of bone marrow stromal stem cells (BMSC) is an important pathway for GC to reduce bone formation. Recent studies implicated an important role of peroxisome proliferator-activated receptor-gamma (PPAR-γ) in GC-mediated cell proliferation and differentiation. Thus, our purpose is to investigate the role of PPAR-γ in regulating rat BMSC (rBMSC) osteoblastic differentiation.
Methods:
The rBMSC treated with dexamethasone (Dex) was used to construct an in vitro cell model of GC-induced osteoporosis. The expressions of PPAR-γ, RUNX2, ALP, OPN and SFRP5 in cells were detected by RT-qPCR and western blot assays. Osteogenic differentiation of rBMSC was measured by Alizarin Red S (ARS) staining analysis. Lentivirus-delivered shRNA was used to knock down PPAR-γ or SFRP5, and lentivirus-delivered constructs were used to overexpress SFRP5 in rBMSC to verify the effect of PPAR-γ or SFRP5 on cell osteogenic differentiation.
Results:
Dex significantly reduced rBMSC osteoblastic differentiation. The expression of PPAR-γ was enhanced in Dex treated rBMSC. PPAR-γ down-regulation improved Dex inhibition of rBMSC osteogenic differentiation. Moreover, PPAR-γ knockdown promoted protein levels of RUNX2, ALP, OPN and Dex-decreased rBMSC osteogenic differentiation. The expression of SFRP5 was reduced while Wnt and β-catenin were increased in PPAR-γ knockdown and Dex treated rBMSC. Moreover, the up-regulation of SFRP5 reversed the osteogenic differentiation of rBMSC induced by PPAR-γ knockdown.
Conclusion:
These data indicated that in GC-induced osteoporosis, PPAR-γ/SFRP5 affects osteogenic differentiation by regulating the Wnt/β-catenin signaling pathway.
Insights
Glucocorticoids (GC) inhibit bone formation by affecting osteoblastic differentiation. This study shows that peroxisome proliferator-activated receptor-gamma (PPAR-γ) plays a key role in this process, impacting the Wnt/β-catenin pathway.
Area of Science:
- Cell Biology
- Stem Cell Research
- Endocrinology
Background:
- Glucocorticoids (GC) inhibit bone formation by suppressing osteoblastic differentiation of bone marrow stromal stem cells (BMSC).
- Peroxisome proliferator-activated receptor-gamma (PPAR-γ) has been implicated in GC-mediated cellular processes.
- The precise role of PPAR-γ in GC-induced inhibition of osteoblastogenesis remains to be fully elucidated.
Purpose of the Study:
- To investigate the role of PPAR-γ in regulating osteoblastic differentiation of rat bone marrow stromal stem cells (rBMSC) under glucocorticoid treatment.
- To explore the molecular mechanisms underlying PPAR-γ's influence on GC-induced suppression of osteogenesis.
Main Methods:
- Established an in vitro model of GC-induced osteoporosis using dexamethasone (Dex)-treated rBMSC.
- Quantified the expression of PPAR-γ, RUNX2, ALP, OPN, and SFRP5 using RT-qPCR and Western blot.
- Assessed osteogenic differentiation via Alizarin Red S staining and manipulated PPAR-γ and SFRP5 levels using lentiviral vectors.
Main Results:
- Dexamethasone significantly inhibited rBMSC osteoblastic differentiation and increased PPAR-γ expression.
- Downregulation of PPAR-γ ameliorated the inhibitory effects of Dex on osteogenesis and promoted key osteogenic markers.
- PPAR-γ knockdown led to decreased SFRP5 and increased Wnt/β-catenin signaling, which was reversed by SFRP5 overexpression.
Conclusions:
- PPAR-γ plays a critical role in mediating the inhibitory effects of glucocorticoids on osteoblastic differentiation.
- The PPAR-γ/SFRP5 axis regulates osteogenic differentiation through the Wnt/β-catenin signaling pathway in the context of GC-induced osteoporosis.
Related Concept Videos
TGF - β Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling

